Compare Ares Capital Corporation (ARCC) vs Axogen Inc (AXGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ares Capital Corporation vs Axogen Inc — how do they compare? Ares Capital Corporation trades at $19.97 (market cap $14.34B), while Axogen Inc trades at $48.21 (market cap $2.61B). The key difference: Ares Capital Corporation is far larger — about 5.5× Axogen Inc's market cap, and Ares Capital Corporation pays a 9.61% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| ARCC | AXGN | |
|---|---|---|
Market Cap | $14.34B | $2.61B |
Sector | Financials | Technology |
52-Week High | $22.68 | $48.48 |
52-Week Low | $17.45 | $14.16 |
Dividend Yield | 9.61% | — |
Enterprise Value | — | $2.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ares Capital Corporation
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in U.S. middle-market companies with investment opportunities as well as in larger companies. Its portfolio comprises of first lien senior secured loans, second lien senior secured loans, and mezzanine debt (subordinated unsecured loan), which may include equity components that are diversified by industry and sector. The company may invest in preferred and common equity investments to a lesser proportion. Its revenue mainly consists of interest and dividend income received from the investment made.
Read more on ARCC →About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →
